Morr H, Nink M, Ferlinz R
Klinik für Lungen- und Bronchialerkrankungen Waldhof Elgershausen, Greifenstein.
Pneumologie. 1990 Apr;44(4):739-43.
In a multicentre, single-blind study, the bronchospasmolytic effect of a single oral dose of tulobuterol 2.0 mg and of fenoterol 2.5 mg was compared in 26 patients suffering from reversible airways obstruction. The bronchospasmolysis achieved with the oral application of tulobuterol and fenoterol is qualitatively satisfactory and reliable, the effect of tulobuterol persisting for a longer period than that of fenoterol.
在一项多中心、单盲研究中，对26例患有可逆性气道阻塞的患者比较了单次口服2.0毫克妥洛特罗和2.5毫克非诺特罗的支气管解痉作用。口服妥洛特罗和非诺特罗所实现的支气管解痉在质量上令人满意且可靠，妥洛特罗的作用持续时间比非诺特罗更长。
